• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Accutane Goes Generic

Article

The first generic version of Accutane (isotretinoin), approved Nov. 11 by the FDA, reached market in late November at a price approximately 5.5 percent lower than the brand name.

Recent Videos
Related Content
Rituximab May Provide Alternative Treatment Option for Epidermolysis Bullosa Acquisita

Rituximab May Provide Alternative Treatment Option for Epidermolysis Bullosa Acquisita

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp

First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp

Article
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD

The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD

Podcast
Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says

Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says

Article
Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised

Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised

Article
© 2024 MJH Life Sciences

All rights reserved.